ÂÜÀòÂÒÂ×

Elisabeth Björk is an endocrinologist by training and an associate professor of medicine at Uppsala University, Sweden. Elisabeth Björkis the Senior Vice President, Head of Late-stage Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D at AstraZeneca leading the global development of medicines within this area. Throughout her career at AstraZeneca, she has gained broad drug development experience covering clinical development phase I-IV, large outcomes programs, major global filings and health authority interactions (FDA, EMA, Japan), and commercial strategy/implementation.

She holds an MD degree, from Karolinska Institute, Stockholm, and Associate Professor, Medicine, at Uppsala University.